Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Sodium Bicarbonate

From Pharmacopedia
Revision as of 04:41, 23 May 2026 by MDElliottMD (talk | contribs) (home-claude punt-list stub-split, Top 300 #227)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Sodium bicarbonate is a systemic alkalinizing agent and antacid, used intravenously in severe metabolic acidosis, hyperkalemia with cardiotoxicity, tricyclic-antidepressant overdose with QRS widening, and (historically) cardiac arrest; orally as an antacid and urinary alkalinizer; and as the carrier base for many effervescent formulations[1]. Routine bicarbonate administration in cardiac arrest was removed from ACLS algorithms because it did not improve survival and worsened intracellular acidosis; the remaining strong indications are narrow and physiology-driven.

Sodium bicarbonate
Neut, many generic; OTC oral: Alka-Seltzer (with aspirin/citric acid), baking soda

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Common uses
Severe metabolic acidosis0, Hyperkalemia with ECG changes0, Tricyclic-antidepressant overdose with QRS widening0, Urinary alkalinization (salicylate or methotrexate toxicity, uric-acid stones)0, Symptomatic antacid (oral)0
Pharmacy
Starting dose
IV: 1 mEq/kg bolus in arrest indication, then titrated to ABG and clinical status; PO: 325-2000 mg up to QID as antacid
Preparations
4.2%, 7.5%, 8.4% IV (1 mEq/mL at 8.4%); 325, 650 mg oral tablets; bulk powder
US FDA Max
No fixed maximum; titrated to pH and bicarbonate level; chronic high oral doses cause metabolic alkalosis and volume overload
Pharmacology
Routes
IV, oral
Onset
Immediate (IV); within minutes (oral antacid)
Duration
IV: hours, dependent on ongoing acid load; oral antacid: ~30 minutes
Half-life
Not applicable (electrolyte and buffer)
Bioavailability
100% (IV); rapidly neutralized by gastric acid (oral)
Pregnancy
Routine antacid and acidosis correction acceptable
Legal status
Rx-only for IV formulations; OTC for oral
Purported mechanism
Sodium bicarbonate raises serum pH directly via the carbonic acid / bicarbonate buffer system; in TCA overdose its benefit is partly pH-driven (reducing free drug) and partly sodium-driven (overcoming TCA sodium-channel blockade), which is why hypertonic 8.4% is preferred over isotonic.0 Bicarbonate is not benign: high-volume use produces hypernatremia, metabolic alkalosis, hypokalemia, and (in arrest) paradoxical intracellular acidosis[1].

References

  1. 1.0 1.1 FDA Prescribing Information, Sodium Bicarbonate Injection, Hospira, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018802s022lbl.pdf